43110 Deucravacitinib, a Selective Tyrosine Kinase 2 Inhibitor, in Japanese Patients With Plaque Psoriasis: PASI Body Region and Component Scores in a Phase 3 Trial

Journal of The American Academy of Dermatology(2023)

引用 0|浏览4
暂无评分
关键词
plaque psoriasis,selective tyrosine kinase,deucravacitinib,inhibitor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要